How is physical activity measured in lung cancer?A systematic review of outcome measures and their psychometric properties

Respirology

Volumn 22, Issue 2, 2017, Pages 263-277

  Edbrooke, Lara ^a   Denehy, Linda ^a,b   Parry, Selina M ^a   Astin, Ronan ^c   Jack, Sandy ^d   Granger, Catherine L ^a,b,e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b INSTITUTE FOR BREATHING AND SLEEP   (Australia)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

lung neoplasms; motor activity; patient outcome assessment; physical modalities; review

Indexed keywords

ACCELEROMETER; ACCELEROMETRY; CALORIMETER; CALORIMETRY; CONCURRENT VALIDITY; CONSTRUCT VALIDITY; CRITERION RELATED VALIDITY; FACE VALIDITY; GODIN LEISURE TIME EXERCISE QUESTIONNAIRE; HUMAN; INTERRATER RELIABILITY; INTRARATER RELIABILITY; LUNG CANCER; MEASUREMENT ERROR; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; PATIENT-REPORTED OUTCOME; PEDOMETER; PEDOMETRY; PHYSICAL ACTIVITY; PHYSICAL CAPACITY; PREDICTIVE VALIDITY; QUESTIONNAIRE; REVIEW; SMALL CELL LUNG CANCER; SYSTEMATIC REVIEW; EXERCISE; HEALTH STATUS; LUNG TUMOR; PSYCHOMETRY; REPRODUCIBILITY;

EXERCISE; HEALTH STATUS; HUMANS; LUNG NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT REPORTED OUTCOME MEASURES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SURVEYS AND QUESTIONNAIRES;

EID: 85009727778     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12975     Document Type: Review

References (62)

1. World Health Organisation. Global recommendations on physical activity for health, 2010. Available from URL: http://www.who.int/dietphysicalactivity/pa/en/.
2. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med. Sci. Sports Exerc. 2010; 42: 1409–26.
3. Stevinson C, Lydon A, Amir Z. Adherence to physical activity guidelines among cancer support group participants. Eur. J. Cancer Care 2014; 23: 199–205.
4. Granger CL, McDonald CF, Irving L, Clark RA, Gough K, Murnane A, Mileshkin L, Krishnasamy M, Denehy L. Low physical activity levels and functional decline in individuals with lung cancer. Lung Cancer 2014; 83: 292–9.
5. World Health Organisation. [Accessed 1 Aug 2016.] Available from URL: http://www.who.int/mediacentre/factsheets/fs385/en/.
6. Tudor-Locke C, Craig CL, Aoyagi Y, Bell RC, Croteau KA, De Bourdeaudhuij I, Ewald B, Gardner AW, Hatano Y, Lutes LD et al. How many steps/day are enough? For older adults and special populations. Int. J. Behav. Nutr. Phys. Act. 2011; 8: 80.
7. Jones LW, Hornsby WE, Goetzinger A, Forbes LM, Sherrard EL, Quist M, Lane AT, West M, Eves ND, Gradison M et al. Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer. Lung Cancer 2012; 76: 248–52.
8. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA 2005; 293: 2479–86.
9. Crandall K, Maguire R, Campbell A, Kearney N. Exercise intervention for patients surgically treated for non-small cell lung cancer (NSCLC): a systematic review. Surg. Oncol. 2014; 23: 17–30.
10. Granger CL, McDonald C, Berney S, Chao C, Denehy L. Exercise intervention to improve exercise capacity and health related quality of life for patients with non-small cell lung cancer: a systematic review. Lung Cancer 2011; 72: 139–53.
11. Cyarto EV, Myers A, Tudor-Locke C. Pedometer accuracy in nursing home and community-dwelling older adults. Med. Sci. Sports Exerc. 2004; 36: 205–9.
12. Macko R, Haeuber E, Shaughnessy M, Coleman K, Boone D, Smith G, Silver K. Microprocessor-based ambulatory activity monitoring in stroke patients. Med. Sci. Sports Exerc. 2002; 34: 6.
13. Portney L, Watkins M. Foundations of Clinical Research. Applications to Practice, 1 edn. NJ, Pearson Education, New Jersey, 1993.
14. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700.
15. Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, Patrick DL, Bouter LM, de Vet HC. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med. Res. Methodol. 2010; 10: 22.
16. Terwee CB, COSMIN Group. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med. Res. Methodol. 2010; 10: 22.
17. Granger C, McDonald C, Parry S, Oliveira C, Denehy L. Functional capacity, physical activity and muscle strength assessment of individuals with non-small cell lung cancer: a systematic review of instruments and their measurement properties. BMC Cancer 2013; 13: 135.
18. Terwee CB, Mokkink LB, Knol DL, Ostelo RW, Bouter LM, de Vet H. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual. Life Res. 2012; 21: 651–7.
19. Du-Quiton J, Wood PA, Burch JB, Grutsch JF, Gupta D, Tyer K, Lis CG, Levin RD, Quiton DF, Reynolds JL et al. Actigraphic assessment of daily sleep-activity pattern abnormalities reflects self-assessed depression and anxiety in outpatients with advanced non-small cell lung cancer. Psychooncology 2010; 19: 180–9.
20. Grutsch JF, Ferrans C, Wood PA, Du-Quiton J, Quiton DF, Reynolds JL, Ansell CM, Oh EY, Daehler MA, Levin RD et al. The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer. BMC Cancer 2011; 11: 193.
21. Grutsch JF, Wood PA, Du-Quiton J, Reynolds JL, Lis CG, Levin RD, Ann Daehler M, Gupta D, Quiton DF, Hrushesky WJ. Validation of actigraphy to assess circadian organization and sleep quality in patients with advanced lung cancer. J. Circadian Rhythms 2011; 9: 4.
22. Levin RD, Daehler MA, Grutsch JF, Quiton J, Lis CG, Peterson C, Gupta D, Watson K, Layer D, Huff-Adams S et al. Circadian function in patients with advanced non-small-cell lung cancer. Br. J. Cancer 2005; 93: 1202–8.
23. Maddocks M. Physical activity level as an outcome measure for use in cancer cachexia trials: a feasibility study. Support. Care Cancer 2010; 18: 1539–44.
24. Maddocks M, Lewis M, Chauhan A, Manderson C, Hocknell J, Wilcock A. Randomized controlled pilot study of neuromuscular electrical stimulation of the quadriceps in patients with non-small cell lung cancer. J. Pain Symptom Manage. 2009; 38: 950–6.
25. Maddocks M, Wilcock A. Exploring physical activity level in patients with thoracic cancer: implications for use as an outcome measure. Support. Care Cancer 2012; 20: 1113–6.
26. Granger CL, Denehy L, McDonald CF, Irving L, Clark RA. Physical activity measured using global positioning system tracking in non-small cell lung cancer: an observational study. Integr. Cancer Ther. 2014; 13: 482–92.
27. Agostini PJ, Naidu B, Rajesh P, Steyn R, Bishay E, Kalkat M, Singh S. Potentially modifiable factors contribute to limitation in physical activity following thoracotomy and lung resection: a prospective observational study. J. Cardiothorac. Surg. 2014; 9: 128.
28. Arai H, Hirai K, Harada K, Tokoro A. Physical activity and psychological adjustment in Japanese advanced lung cancer patients in chemotherapy: the feasibility of intervention. Int. J. Sport Health Sci. 2010; 8: 15–21.
29. Le Guen Y, Gagnadoux F, Hureaux J, Jeanfaivre T, Meslier N, Racineux JL, Urban T. Sleep disturbances and impaired daytime functioning in outpatients with newly diagnosed lung cancer. Lung Cancer 2007; 58: 139–43.
30. van der Meij BS, Langius JA, Spreeuwenberg MD, Slootmaker SM, Paul MA, Smit EF, van Leeuwen PA. Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT. Eur. J. Clin. Nutr. 2012; 66: 399–404.
31. Novoa N, Varela G, Jimenez MF, Aranda JL. Influence of major pulmonary resection on postoperative daily ambulatory activity of the patients. Interact. Cardiovasc. Thorac. Surg. 2009; 9: 934–8.
32. Novoa NM, Varela G, Jimenez MF, Ramos J. Value of the average basal daily walked distance measured using a pedometer to predict maximum oxygen consumption per minute in patients undergoing lung resection. Eur. J. Cardiothorac. Surg. 2011; 39: 756–62.
33. Hoffman AJ, Brintnall RA, Brown JK, Eye A, Jones LW, Alderink G, Ritz-Holland D, Enter M, Patzelt LH, Vanotteren GM. Too sick not to exercise: using a 6-week, home-based exercise intervention for cancer-related fatigue self-management for postsurgical non-small cell lung cancer patients. Cancer Nurs. 2013; 36: 175–88.
34. Gibney E, Elia M, Jebb SA, Murgatroyd P, Jennings G. Total energy expenditure in patients with small-cell lung cancer: results of a validated study using the bicarbonate-urea method. Metabolism 1997; 46: 1412–7.
35. Jones LW, Peddle CJ, Eves ND, Haykowsky MJ, Courneya KS, Mackey JR, Joy AA, Kumar V, Winton TW, Reiman T. Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions. Cancer 2007; 110: 590–8.
36. Coups EJ, Ostroff JS, Steingart RM, Feinstein MB, Wilson D. Exercise patterns in lung cancer survivors. Psychooncology 2006; 15: 498.
37. Philip EJ, Coups EJ, Feinstein MB, Park BJ, Wilson DJ, Ostroff JS. Physical activity preferences of early-stage lung cancer survivors. Support. Care Cancer 2014; 22: 495–502.
38. Coups EJ, Park BJ, Feinstein MB, Steingart RM, Egleston BL, Wilson DJ, Ostroff JS. Physical activity among lung cancer survivors: changes across the cancer trajectory and associations with quality of life. Cancer Epidemiol. Biomarkers Prev. 2009; 18: 664–72.
39. Feinstein MB, Krebs P, Coups EJ, Park BJ, Steingart RM, Burkhalter J, Logue A, Ostroff JS. Current dyspnea among long-term survivors of early-stage non-small cell lung cancer. J. Thorac. Oncol. 2010; 5: 1221–6.
40. Lin YY, Wu YC, Rau KM, Lin CC. Effects of physical activity on the quality of life in Taiwanese lung cancer patients receiving active treatment or off treatment. Cancer Nurs. 2013; 36: E35–41.
41. Granger CL, Parry SM, Denehy L. The self-reported Physical Activity Scale for the Elderly (PASE) is a valid and clinically applicable measure in lung cancer. Support. Care Cancer 2015; 23: 3211–8.
42. Bleehen NM, Girling DJ, Machin D, Stephens RJ. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party. Br. J. Cancer 1993; 68: 1157–66.
43. Cheville AL, Novotny PJ, Sloan JA, Basford JR, Wampfler JA, Garces YI, Jatoi A, Yang P. The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors. J. Pain Symptom Manage. 2011; 42: 213–21.
44. Souhami RL, Spiro SG, Rudd RM, Ruiz de Elvira MC, James LE, Gower NH, Lamont A, Harper PG. Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy. J. Natl. Cancer Inst. 1997; 89: 577–80.
45. Clark MM, Vickers KS, Hathaway JC, Smith M, Looker SA, Petersen LR, Pinto BM, Rummans TA, Loprinzi CL. Physical activity in patients with advanced-stage cancer actively receiving chemotherapy. J. Support. Oncol. 2007; 5: 487–93.
46. Cooley ME, Finn KT, Wang Q, Roper K, Morones S, Shi L, Litrownik D, Marcoux JP, Zaner K, Hayman LL. Health behaviors, readiness to change, and interest in health promotion programs among smokers with lung cancer and their family members: a pilot study. Cancer Nurs. 2013; 36: 145–54.
47. Geddes DM, Dones L, Hill E, Law K, Harper PG, Spiro SG, Tobias JS, Souhami RL. Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial. Eur. J. Cancer 1990; 26: 484–92.
48. Ishihara Y, Sakai H, Nukariya N, Kobayashi K, Yoneda S, Matsuoka R, Hohjo T, Nishiwaki Y, Hoshi A, Kuratomi Y et al. A diary form quality of life questionnaire for Japanese patients with lung cancer and summarization techniques for longitudinal assessment. Respirology 1999; 4: 53–61.
49. Denehy L, Hornsby WE, Herndon JE 2nd, Thomas S, Ready NE, Granger CL, Valera L, Kenjale AA, Eves ND, Jones LW. Prognostic validation of the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index in inoperable non-small-cell lung cancer. J. Thorac. Oncol. 2013; 8: 1545–50.
50. Schofield E, Ward C, Hickson M, Elkin S. Physical activity levels of lung cancer survivors. Cancer Nurs. Pract. 2014; 13: 31–7.
51. Coups EJ, Park BJ, Feinstein MB, Steingart RM, Egleston BL, Wilson DJ, Ostroff JS. Correlates of physical activity among lung cancer survivors. Psychooncology 2009; 18: 395–404.
52. Jacobsen PB, Phillips KM, Jim HS, Small BJ, Faul LA, Meade CD, Thompson L, Williams CC Jr, Loftus LS, Fishman M et al. Effects of self-directed stress management training and home-based exercise on quality of life in cancer patients receiving chemotherapy: a randomized controlled trial. Psychooncology 2013; 22: 1229–35.
53. Jones LW, Eves ND, Peddle CJ, Courneya KS, Haykowsky M, Kumar V, Winton TW, Reiman T. Effects of presurgical exercise training on systemic inflammatory markers among patients with malignant lung lesions. Appl. Physiol. Nutr. Metab. 2009; 34: 197–202.
54. Cooley ME, Short TH, Moriarty HJ. Symptom prevalence, distress, and change over time in adults receiving treatment for lung cancer. Psychooncology 2003; 12: 694–708.
55. Buccheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur. J. Cancer 1996; 32a: 1135–41.
56. Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR Jr, Tudor-Locke C, Greer JL, Vezina J, Whitt-Glover MC, Leon AS. 2011 Compendium of physical activities: a second update of codes and MET values. Med. Sci. Sports Exerc. 2011; 43: 1575–81.
57. Denehy L, Nordon-Craft A, Edbrooke L, Malone D, Berney S, Schenkman M, Moss M. Outcome measures report different aspects of patient function three months following critical care. Intensive Care Med. 2014; 40: 1862–9.
58. Islam KM, Jiang X, Anggondowati T, Lin G, Ganti AK. Comorbidity and survival in lung cancer patients. Cancer Epidemiol. Biomarkers Prev. 2015; 24: 1079–85.
59. Van Remoortel H, Giavedoni S, Raste Y, Burtin C, Louvaris Z, Gimeno-Santos E, Langer D, Glendenning A, Hopkinson NS, Vogiatzis I et al. Validity of activity monitors in health and chronic disease: a systematic review. Int. J. Behav. Nutr. Phys. Act. 2012; 9: 84.
60. Watz H, Pitta F, Rochester CL, Garcia-Aymerich J, ZuWallack R, Troosters T, Vaes AW, Puhan MA, Jehn M, Polkey MI et al. An official European Respiratory Society statement on physical activity in COPD. Eur. Respir. J. 2014; 44: 1521–37.
61. Vorrink SN, Kort HS, Troosters T, Lammers JW. Level of daily physical activity in individuals with COPD compared with healthy controls. Respir. Res. 2011; 12: 33.
62. Demeyer H, Burtin C, Van Remoortel H, Hornikx M, Langer D, Decramer M, Gosselink R, Janssens W, Troosters T. Standardizing the analysis of physical activity in patients with COPD following a pulmonary rehabilitation program. Chest 2014; 146: 318–27.